Skip to main content

Table 4 Patient characteristics between BRAF V600E and BRAF wild-type MA patients

From: Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases

n Total BRAF V600E BRAF wild-type
27 22 5
Gender F:M = 9:18 F:M = 5:17 F:M = 1:4*
Age range, year 12~ 80 25~ 73 12~ 47**
Median age, year 39 40 29
Tumor size, cm 2~ 7 2.5~ 7 2~ 5.5*
Median size, cm 3.1 3.2 2.2
BCL2, (negative/positive) 5/22 2/20 3/2**
p16, (negative/positive) 4/23 1/21 3/2**
p-MEK, (negative/positive) 0/27 0/22 0/5
p-ERK, (negative/positive) 15/12 13/9 2/3
DUSP6, (negative/positive) 4/23 2/20 2/3
  1. Abbreviations: F female. M male. * p < 0.05, **p < 0.01 compared to BRAF V600E group. Statistical analysis was performed by Chi-square test